Timothy Stout, MD
Retina Specialist · Knoxville, TNNPI 1316930688
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Daiichi Sankyo Inc. at 57.8% of the total. Reporting peaked in 2023 at $4,506 and has fallen 99.1% since, to $42 in 2025.
Across 99 payments — averaging $128.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$7K
- Janssen Research & Development, LLC$1K
- Novartis$1K
- AbbVie$718
- Biotissue Holdings Inc.$521
- Sight Sciences, Inc.$498
- plus $1K from 18 others
Across 10 payments — averaging $18,512 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$184K
- Janssen Research & Development, LLC$1K
What the payments were for
- Consulting fees$7,35058%
- Travel & lodging$1,74814%
- Food & beverage$3,62929%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $7,350 |
| Janssen Research & Development, LLC | 10 | $1,188 |
| Novartis | 13 | $1,146 |
| AbbVie(2 entities) | 9 | $718 |
| Biotissue Holdings Inc. | 8 | $521 |
| Sight Sciences, Inc. | 8 | $498 |
| Alcon | 5 | $228 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 8 | $213 |
| Eyepoint US, Inc. | 2 | $167 |
| Omeros Corporation | 1 | $135 |
| Mallinckrodt Hospital Products Inc. | 5 | $96 |
| Kala Pharmaceuticals, Inc. | 4 | $70 |
| Aerie Pharmaceuticals, Inc. | 4 | $67 |
| Sun Pharmaceutical Industries Inc. | 3 | $60 |
| Bausch & Lomb Americas Inc. | 3 | $60 |
| Mallinckrodt Enterprises LLC | 3 | $49 |
| Oyster Point Pharma, Inc. | 2 | $41 |
| Rxsight Inc | 1 | $24 |
| Eyevance Pharmaceuticals LLC | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| Tarsus Pharmaceuticals, Inc. | 1 | $17 |
| ANI Pharmaceuticals, Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $13 |
| Ocular Therapeutix, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BEOVU$782
- OMNI(R) SURGICAL SYSTEM (US)$295
- DEXYCU$154
- OMIDRIA$135
- AcrySof$133
- OMNI$126
- LOTEMAX SM$119
- OZURDEX$118
- VUITY$110
- DURYSTA$107
How this compares
$12,727 in reported general payments places this provider in the 70th percentile of 58 retina specialist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 36 | $1,775 |
| Prednisolone Acetate | 35 | $1,321 |
| Latanoprost | 36 | $303 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 12 | $184 |
| Doxycycline Hyclate | 19 | $138 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Knoxville
- Nicholas AndersonKnoxville$46K
- Jacob CoxKnoxville$6K
- Jonathan FuerstKnoxville$3K
- Robert ShulerKnoxville$3K
- James MillerKnoxville$3K
- Joseph GoogeKnoxville$2K
- Stephen PerkinsKnoxville$2K
- Ailee LahamKnoxville$2K
- Tod McMillanKnoxville$850
- Steve CharlesGermantown$5.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.